obesity drug news today glp-1 september 29 2025 President Trump announced that Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for weight management indications for people with obesity. Our senior staff writer Kristen Monaco Lilly hikes revenue forecasts on

HUBERMAN: We have it in mind that it's involved in these pathways, but I should say every time we look at a given peptide, whether or not it's ghrelin or hypocretinorexin or it's GLP-1, What we find is that, again, there are these pleiotropic effects

J Cutan Pathol (2019) 46:87887

Working closely with a gynecologist or reproductive endocrinologist can help address fertility concerns

The GHK-Cu hair growth before and after timeline looks like this: Weeks 1 to 6: Possible mild shedding

This once-daily tablet supports appetite regulation and digestion, making weight management more accessible for individuals who prefer an oral medication